The role of the immunoinflammatory response after cardiac arrest by Sandu, Nora et al.
The role of the immunoinflammatory response after
cardiac arrest
Commentary on
The role of the immuno-inflammatory response in patients after cardiac arrest
Anna Samborska-Sablik, Zbigniew Sablik, Wojciech Gaszynski
Arch Med Sci 2011; 7, 4: 619-626
Nora Sandu
1, Amr Abdulazim
2, Toma Spiriev
1, Belachew Arasho
1,3, Bernhard Schaller
1
Cardiac arrest is a good (experimental) model for research in ischaemic
tolerance [1], so it has been used often during the last 20 years in animal
models. The (global) ischaemic event induced by cardiac arrest is followed by
a phase of ischaemic preconditioning if the initial phase was of shorter or
even stroke/complete ischaemia if the initial phase was of longer duration
[2]. During the last years, there has been great effort in different research
groups all over the world to find out the underlying pathophysiological
mechanisms involved after these events or at least to find out some risk
factors either in the brain or in the whole body [3, 4].
InthepresentissueofArchivesofMedicalScience,AnnaSamborska-Sablik
et al. present an interesting manuscript that deals with the role of the
immunoinflammatory response after cardiac arrest in humans [5]. It is one
of the very few studies in humans after cardiac arrest and is therefore of
special interest [6]. The authors could find a significant correlation of the
post-cardiac-arrest immunoinflammatory response (hs-CRP and IL-6) with
the patients’ clinical state and also with the prediction of survival [5]. Such
data are in line with previous research in the brain [7, 8] and open the door
to so-called “immunomodulatory therapy”. In the brain such research is
advanced, but we need a better understanding of the brain and immune
system after such ischaemic events [9]. For the whole body, nearly no data
existsofar.However,AnnaSamborska-Sabliketal.havenowprovidedabetter
insightintotheclinicalrelevanceofsuchresearch[5]:Theyshowtherelevance
of this immunoinflammatory response for Glasgow Coma Scale (GCS) and
Acute Physiology and Chronic Health Evaluation II (APACHE II) score: two of
the major scores used in clinical daily practice. Therefore the
immunoinflammatory response after ischaemic events is not only an
experimental phenomenon (as many others), but also of great clinical
importance [10, 11]. What are now the therapeutic implications of these
findings?Inexperimentalstudies,preventiveantibiotictreatmentdramatically
improved survival and outcome after ischaemic events, and even reduced
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the organ’s infarct size area [9, 12]. Apart from these
experimental studies there are several clinical trials
with promising results in this direction [12]. Smaller
events of shorter duration can be protective – for
example in the postoperative period – for further
ischaemic events [7].
In this context, the oxygen-conserving reflex has
gained more interest [13, 14] and can explain – at least
partly – why the brain is only damaged after a very
long duration of cardiac arrest. Nevertheless, the
article of Samborska-Sablik et al. [5] goes deep into
the pathophysiology of different organs. Further
clinical research on this topic will open widely the
doors to interesting therapeutic modalities and will
help to resolve one of the great problems in internal
medicine. Let’s go on this way! 
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